Quantcast

Scientists at Fred Hutchinson Cancer Research Center have cleared a major technical hurdle to making umbilical-cord-blood transplants a more widely-used method for treating leukemia and other blood cancers.

In a study published in the Jan.17 edition of Nature Medicine, Colleen Delaney,M.D., and colleagues describe the first use of a method to vastly expand the number of stem/progenitor cells from a unit of cord blood in the laboratory that were then infused into patients resulting in successful and rapid engraftment.

1 Comment

  • Peter says:

    The leukemia research is truly amazing, but just as much the progress in multiplying the stem cells from lesser volumes. Proponents of cord blood banking often argue there’s simply not enough cells for adult treatments, but this type of progress should help to change that soon.

Leave a Reply

Your email address will not be published. Required fields are marked *

*